PrP Assay Correlates With Bioassay; WHO Calls For TSE Reference Materials
This article was originally published in The Gray Sheet
Executive Summary
Clearance of protease-resistant prion proteins (PrP-SC or PrP-RES) appears to correlate with clearance of transmissible spongiform encephalopathy (TSE) infection, Bayer pathogen safety researcher Douglas Lee, PhD, reported at FDA's Sept. 13-14 International Workshop on Clearance of TSE Agents from Blood Products.
You may also be interested in...
Panel Recommends Human Dura Mater Reclassification Into Class II
Processed human dura mater should be classified as a Class II device, FDA's Neurological Devices Panel unanimously (7-0) recommended Sept. 17 at a meeting in Gaithersburg, Maryland.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”